An improved synthesis of biotinol-5′-AMP, an acyl-AMP mimic of the natural reaction intermediate of biotin protein ligase (BPL), is reported. This compound was shown to be a pan inhibitor of BPLs from a series of clinically important bacteria, particularly Staphylococcus aureus and Mycobacterium tuberculosis, and kinetic analysis revealed it to be competitive against the substrate biotin. Biotinol-5′-AMP also exhibits antibacterial activity against a panel of clinical isolates of S. aureus and M. tuberculosis with MIC values of 1−8 and 0.5−2.5 μg/mL, respectively, while being devoid of cytotoxicity to human HepG2 cells. KEYWORDS: Antibiotics, enzyme inhibitors, biotin protein ligase, chemical synthesis, drug design A denylate-forming enzymes play a central role in many key metabolic pathways such as ribosomal and nonribosomal peptide synthesis, fatty acid synthesis, and enzyme regulation. As such they are of significant interest as potential drug targets. 1,2 These enzymes function by activating a carboxylate metabolite on reaction with ATP to form an acyl-AMP intermediate, which then reacts with a nucleophile to generate the desired product ( Figure 1). The acyl-AMP reaction intermediates possess a high binding affinity for the enzyme, often 2−3 orders of magnitude greater than the carboxylic acid or ATP substrates. 3,4 The inhibition of biotinyl-5′-AMP 1, one such intermediate produced by the biotin protein ligase (BPL) catalyzed reaction of biotin and ATP, has attracted recent interest as a potential new class of antibiotic. 5,6 An important approach to these inhibitors involves replacing the hydrolytically unstable acyl phosphate linker of 1 with a more stable bioisostere, as in biotinol-5′-AMP 2. 6,7 This phosphodiester mimic is a potent inhibitor of BPLs from S. aureus, Escherichia coli, and Homo sapiens. 6,8 However, its antibacterial properties have not been investigated. Other acyl phosphate bioisosteres used in this context include, sulfonyl and 1,2,3-triazole groups, among others. 5,6,9−25 Importantly, acyl-AMP mimics (containing sulfonmyl and 1,2,3-triazole isosteres, see 3 and 4 in Figure 1) have been shown to be potent agents against M. tuberculosis and S. aureus, respectively. 26 Given the central importance of biotinol-5′-AMP 2 as a BPL inhibitor, we now report an expedient method for its synthesis and an investigation of its activity profile against clinically significant bacteria.Biotinol-5′-AMP 2 is reportedly prepared according to a modified "phosphodiester" procedure as shown in Scheme 1. 7 However, in our hands this procedure gave an unsatisfactory overall yield of 9% from adenosine 5. The key limitation with this procedure was a DCC mediated coupling of 6 and 8 to give phosphodiester 9, with subsequent in situ deprotection of the acetonide group to give 2. An overall yield of 15% was obtained over these two steps. Attempts to optimize the DCC coupling step using other solvents, particularly pyridine or DMF, or longer reaction times (up to 48 h) failed to improve the yield. The u...